EUVIMEDEUVIMED entdecken
Crossref

INDIGENOUS MICROALGA (CHLORELLA SOROKINIANA SM1) ISOLATION, CARBON CAPTURE POTENTIAL AND PHARMACEUTICAL METABOLITE PROFILING

Minaj Mulani, Vidya Kothari, Satyam Pawar, Harichandra Nikule, Sunil Bhagat, Parimita Jadhav, Jayant Pralhad Rathod

International Journal of Drug Delivery Technology · 08.06.2026 · 16 (48s)

DOI: 10.25258/ijddt.16.48s.79 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Minaj Mulani und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microalgae are becoming widely recognized as efficient agents for sustainable carbon capture and bioactive metabolite production with potent pharmaceutical applications. At present there is an argent need for biobased pharmaceutical bio compounds.

Objectives

To isolate new microalgal species for carbon capture and utilization as biopharma products and confirm the presence of bioactive compounds.

Methods

Traditional methods of serial dilutions from soil, monoculture establishment, morphological analysis, axenic culture development, molecular identification were carried out for the identification of indigenous microalgal species. Microalga Chlorella sorokiniana SM1 growth analysis, pigment profile and theoretical carbon capture potential was carried out. The LCMS analysis was performed using Chlorella sorokiniana SM1 extract for the identification of potential pharmaceutical compounds.

Results

The indigenous microalga Chlorella sorokiniana SM1, a novel strain, was isolated, made axenic and identified using molecular techniques. The cells were spherical in size and were around 2.68 µm in diameter. The biomass of isolated Chlorella sorokiniana SM1 strain was 0.74 g/L as compared to 0.63 g/L of already known Chlorella sorokiniana species used for comparison purposes. The theoretical C capture potential of the isolated Chlorella sorokiniana SM1 and Chlorella sorokiniana were calculated to be 1.33 and 1.13g/g biomass respectively, which was 37.5% higher. Chlorophyll a, b and carotenoids of the isolated strain were found to be 14%, 16& and 33% greater than that of known Chlorella sorokiniana. Also, 23 unique bioactive substances, including metabolites with possible antibacterial, antiviral, anticancer, antidiabetic, antioxidant, and anti-inflammatory qualities, were found by LC-MS analysis.

Conclusion

Overall, the findings highlight the dual utility of Chlorella sorokiniana SM1 in climate change mitigation and pharmaceutical applications, positioning C. sorokiniana SM1 as a promising candidate for integrated environmental and pharmaceutical industry sustainability.

Zitieren

APA

Mulani, M., Kothari, V., Pawar, S., Nikule, H., Bhagat, S., Jadhav, P., & Rathod, J. P. (2026). INDIGENOUS MICROALGA (CHLORELLA SOROKINIANA SM1) ISOLATION, CARBON CAPTURE POTENTIAL AND PHARMACEUTICAL METABOLITE PROFILING. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.79

Vancouver

Mulani M, Kothari V, Pawar S, Nikule H, Bhagat S, Jadhav P, et al. INDIGENOUS MICROALGA (CHLORELLA SOROKINIANA SM1) ISOLATION, CARBON CAPTURE POTENTIAL AND PHARMACEUTICAL METABOLITE PROFILING. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.79

BibTeX
@article{Mulani2026,
  author = {Mulani, Minaj and Kothari, Vidya and Pawar, Satyam and Nikule, Harichandra and Bhagat, Sunil and Jadhav, Parimita and Rathod, Jayant Pralhad},
  title = {INDIGENOUS MICROALGA (CHLORELLA SOROKINIANA SM1) ISOLATION, CARBON CAPTURE POTENTIAL AND PHARMACEUTICAL METABOLITE PROFILING},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {48s},
  doi = {10.25258/ijddt.16.48s.79}
}
Kostenlos starten →